Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cardio Diagnostics Holdings (CDIO) Income from Continuing Operations (2021 - 2025)

Cardio Diagnostics Holdings' Income from Continuing Operations history spans 5 years, with the latest figure at 1714536.0 for Q3 2025.

  • For Q3 2025, Income from Continuing Operations fell 21.38% year-over-year to 1714536.0; the TTM value through Sep 2025 reached 6552107.0, up 20.61%, while the annual FY2024 figure was 8383453.0, 0.08% changed from the prior year.
  • Income from Continuing Operations for Q3 2025 was 1714536.0 at Cardio Diagnostics Holdings, down from 1683199.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 202269.0 in Q3 2022 and bottomed at 4163584.0 in Q1 2024.
  • The 5-year median for Income from Continuing Operations is 1400747.5 (2023), against an average of 1402604.56.
  • The largest YoY upside for Income from Continuing Operations was 28153.95% in 2022 against a maximum downside of 211990.18% in 2022.
  • A 5-year view of Income from Continuing Operations shows it stood at 144837.0 in 2021, then tumbled by 1541.89% to 2378057.0 in 2022, then skyrocketed by 41.59% to 1388929.0 in 2023, then decreased by 9.39% to 1519308.0 in 2024, then decreased by 12.85% to 1714536.0 in 2025.
  • Per Business Quant, the three most recent readings for CDIO's Income from Continuing Operations are 1714536.0 (Q3 2025), 1683199.0 (Q2 2025), and 1635064.0 (Q1 2025).